Ponalrestat
Ponalrestat, an aldose reductase inhibitor, activates lipoprotein lipase (LPL) activity in the adipose tissue and alleviates the cachectic symptoms induced by B16 melanoma in mice
Product Specifications
CAS Number
72702-95-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
391.19
Molecular Formula
C17H12BrFN2O3
Notes
Research use only, not for human use.
Receptor
Aldose reductase
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6349824-01 0.1 mL
SORCS1, NT (SORCS1, SORCS, VPS10 domain-containing receptor SorCS1) (MaxLight 750)
Ask
View Details 
MBS6349824-02 5x 0.1 mL
SORCS1, NT (SORCS1, SORCS, VPS10 domain-containing receptor SorCS1) (MaxLight 750)
Ask
View Details 
